Christopher Morabito Fulcrum Therapeutics, Inc. (FULC) insider trading activity
Christopher Morabito is Chief Medical Officer of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 1,100 shares of FULC, which is worth approximately $4,785. The most recent transaction as insider was on Jun 28, 2021, when has been sold 1,100 shares (Common Stock) at a price of $9.16 per share, resulting in proceeds of $10,076. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.1K
0%
3M change
0%
12M change
Total Value Held
$4,785
Christopher Morabito Transaction History
Also insider at
CM
Christopher Morabito
Chief Medical Officer
Boston, MA